TCPWM
Traverso Chambers Private Wealth Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $618K | Sell |
16,681
-317
| -2% | -$11.7K | 0.15% | 68 |
|
|
2023
Q3 | $616K | Buy |
16,998
+739
| +5% | +$26.8K | 0.16% | 64 |
|
|
2023
Q2 | $579K | Buy |
16,259
+86
| +0.5% | +$3.07K | 0.15% | 65 |
|
|
2023
Q1 | $575K | Buy |
16,173
+260
| +2% | +$9.25K | 0.16% | 68 |
|
|
2022
Q4 | $559K | Buy |
15,913
+283
| +2% | +$9.95K | 0.16% | 67 |
|
|
2022
Q3 | $460K | Buy |
15,630
+9
| +0.1% | +$265 | 0.14% | 73 |
|
|
2022
Q2 | $680K | Buy |
15,621
+406
| +3% | +$17.7K | 0.23% | 57 |
|
|
2022
Q1 | $663K | Sell |
15,215
-52
| -0.3% | -$2.27K | 0.2% | 60 |
|
|
2021
Q4 | $673K | Buy |
15,267
+546
| +4% | +$24.1K | 0.2% | 60 |
|
|
2021
Q3 | $563K | Buy |
14,721
+534
| +4% | +$20.4K | 0.18% | 65 |
|
|
2021
Q2 | $565K | Buy |
14,187
+1,062
| +8% | +$42.3K | 0.18% | 63 |
|
|
2021
Q1 | $468K | Buy |
13,125
+760
| +6% | +$27.1K | 0.16% | 66 |
|
|
2020
Q4 | $455K | Buy |
12,365
+822
| +7% | +$30.2K | 0.16% | 61 |
|
|
2020
Q3 | $434K | Sell |
11,543
-247
| -2% | -$9.29K | 0.17% | 61 |
|
|
2020
Q2 | $481K | Buy |
11,790
+617
| +6% | +$25.2K | 0.2% | 56 |
|
|
2020
Q1 | $423K | Buy |
11,173
+280
| +3% | +$10.6K | 0.2% | 59 |
|
|
2019
Q4 | $512K | Sell |
10,893
-231
| -2% | -$10.9K | 0.22% | 55 |
|
|
2019
Q3 | $475K | Buy |
11,124
+279
| +3% | +$11.9K | 0.23% | 58 |
|
|
2019
Q2 | $444K | Buy |
10,845
+4
| +0% | +$164 | 0.22% | 58 |
|
|
2019
Q1 | $453K | Sell |
10,841
-76
| -0.7% | -$3.18K | 0.22% | 58 |
|
|
2018
Q4 | $417K | Buy |
+10,917
| New | +$417K | 0.23% | 57 |
|